Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Cg Oncology Inc.
Swot
Cg Oncology Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Cg Oncology Inc. has 11 Strengths, 8 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(11)
Weakness
(8)
Opportunity
(5)
Threats
(0)
Others
(1)
Price crossing above SMA20 today, and greater than SMA5
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
MACD crossed above zero line previous end of day
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Top Gainers
Stocks in uptrend most likely to cross above SMA-200 soon
Stock with Low PE (PE < = 10)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Declining profits every quarter for the past 4 quarters
Declining Revenue every quarter for the past 2 quarters
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
